Annual CFF
$6.25 M
-$5.41 M-46.38%
October 31, 2024
Summary
- As of February 8, 2025, CMND annual cash flow from financing activities is $6.25 million, with the most recent change of -$5.41 million (-46.38%) on October 31, 2024.
- During the last 3 years, CMND annual CFF has risen by +$865.10 thousand (+16.05%).
- CMND annual CFF is now -46.38% below its all-time high of $11.66 million, reached on October 31, 2023.
Performance
CMND Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$323.20 K
-$146.30 K-31.16%
October 31, 2024
Summary
- As of February 8, 2025, CMND quarterly cash flow from financing activities is $323.20 thousand, with the most recent change of -$146.30 thousand (-31.16%) on October 31, 2024.
- Over the past year, CMND quarterly CFF has dropped by -$2.08 million (-86.56%).
- CMND quarterly CFF is now -94.91% below its all-time high of $6.35 million, reached on January 31, 2023.
Performance
CMND Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$6.25 M
-$2.08 M-24.98%
October 31, 2024
Summary
- As of February 8, 2025, CMND TTM cash flow from financing activities is $6.25 million, with the most recent change of -$2.08 million (-24.98%) on October 31, 2024.
- Over the past year, CMND TTM CFF has dropped by -$5.41 million (-46.38%).
- CMND TTM CFF is now -46.38% below its all-time high of $11.66 million, reached on October 31, 2023.
Performance
CMND TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CMND Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -46.4% | -86.6% | -46.4% |
| 3 y3 years | +16.1% | +163.9% | +16.1% |
| 5 y5 years | +100.0% | - | - |
CMND Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -46.4% | +1122.3% | -94.9% | +568.4% | -46.4% | +8250.2% |
| 5 y | 5-year | -46.4% | -100.0% | -94.9% | +163.9% | -46.4% | +8250.2% |
| alltime | all time | -46.4% | -100.0% | -94.9% | +163.9% | -46.4% | -100.0% |
Clearmind Medicine Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | $6.25 M(-46.4%) | $323.20 K(-31.2%) | $6.25 M(-25.0%) |
| Jul 2024 | - | $469.50 K(+223.6%) | $8.34 M(+6.4%) |
| Apr 2024 | - | $145.10 K(-97.3%) | $7.84 M(-26.3%) |
| Jan 2024 | - | $5.32 M(+121.0%) | $10.63 M(-8.8%) |
| Oct 2023 | $11.66 M(+2179.5%) | $2.41 M(-7687.7%) | $11.66 M(+26.9%) |
| Jul 2023 | - | -$31.70 K(-101.1%) | $9.19 M(+0.2%) |
| Apr 2023 | - | $2.94 M(-53.6%) | $9.17 M(+33.7%) |
| Jan 2023 | - | $6.35 M(-9300.1%) | $6.86 M(+1240.6%) |
| Oct 2022 | $511.70 K(-90.5%) | -$69.00 K(+42.9%) | $511.70 K(+583.2%) |
| Jul 2022 | - | -$48.30 K(-107.7%) | $74.90 K(-98.4%) |
| Apr 2022 | - | $629.00 K(>+9900.0%) | $4.61 M(-14.4%) |
| Jan 2022 | - | $0.00(-100.0%) | $5.39 M(0.0%) |
| Oct 2021 | $5.39 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2021 | - | -$505.80 K(-111.3%) | $5.39 M(-8.6%) |
| Jul 2021 | - | $4.49 M(+219.6%) | $5.90 M(+314.4%) |
| Apr 2021 | - | $1.40 M(>+9900.0%) | $1.42 M(+216.8%) |
| Oct 2020 | $449.40 K(>+9900.0%) | $3100.00(-79.7%) | $449.30 K(+0.7%) |
| Jul 2020 | - | $15.30 K(-96.4%) | $446.20 K(+3.6%) |
| Apr 2020 | - | $430.90 K(>+9900.0%) | $430.90 K(>+9900.0%) |
| Oct 2019 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Jul 2019 | - | $0.00(0.0%) | $23.40 K(+1850.0%) |
| Apr 2019 | - | $0.00(-100.0%) | $1200.00(-99.2%) |
| Oct 2018 | $158.50 K | $23.40 K(-205.4%) | $158.50 K(+17.3%) |
| Jul 2018 | - | -$22.20 K(+241.5%) | $135.10 K(-14.1%) |
| Apr 2018 | - | -$6500.00(-104.0%) | $157.30 K(-4.0%) |
| Jan 2018 | - | $163.80 K | $163.80 K |
FAQ
- What is Clearmind Medicine annual cash flow from financing activities?
- What is the all time high annual CFF for Clearmind Medicine?
- What is Clearmind Medicine annual CFF year-on-year change?
- What is Clearmind Medicine quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Clearmind Medicine?
- What is Clearmind Medicine quarterly CFF year-on-year change?
- What is Clearmind Medicine TTM cash flow from financing activities?
- What is the all time high TTM CFF for Clearmind Medicine?
- What is Clearmind Medicine TTM CFF year-on-year change?
What is Clearmind Medicine annual cash flow from financing activities?
The current annual CFF of CMND is $6.25 M
What is the all time high annual CFF for Clearmind Medicine?
Clearmind Medicine all-time high annual cash flow from financing activities is $11.66 M
What is Clearmind Medicine annual CFF year-on-year change?
Over the past year, CMND annual cash flow from financing activities has changed by -$5.41 M (-46.38%)
What is Clearmind Medicine quarterly cash flow from financing activities?
The current quarterly CFF of CMND is $323.20 K
What is the all time high quarterly CFF for Clearmind Medicine?
Clearmind Medicine all-time high quarterly cash flow from financing activities is $6.35 M
What is Clearmind Medicine quarterly CFF year-on-year change?
Over the past year, CMND quarterly cash flow from financing activities has changed by -$2.08 M (-86.56%)
What is Clearmind Medicine TTM cash flow from financing activities?
The current TTM CFF of CMND is $6.25 M
What is the all time high TTM CFF for Clearmind Medicine?
Clearmind Medicine all-time high TTM cash flow from financing activities is $11.66 M
What is Clearmind Medicine TTM CFF year-on-year change?
Over the past year, CMND TTM cash flow from financing activities has changed by -$5.41 M (-46.38%)